Supreme Court Offers Companies Pension Liability Relief
Employers dodged a high-powered bullet in mid-June when a unanimous Supreme Court overturned the 9th Circuit Court of Appeals' decision in Beck v. PACE International Union.
July 31, 2007 at 08:00 PM
5 minute read
Employers dodged a high-powered bullet in mid-June when a unanimous Supreme Court overturned the 9th Circuit Court of Appeals' decision in Beck v. PACE International Union. The decision means companies opting to terminate an ERISA pension plan do not have to consider invitations to merge the plan with a union pension fund as an alternative to termination. Merging a plan often means the original plan sponsor forfeits any pension surpluses.
“The implications of the 9th Circuit's decision would have been pretty bad because it suggested the implementation of administrative decisions, even if they were [sponsor] functions of employers, invoked a fiduciary duty,” says Heidi Winzeler, counsel at Osler Hoskin & Harcourt.
The 9th Circuit decision shocked ERISA practitioners and the benefits industry. Before Beck, the industry firmly believed employers could terminate fully funded or overfunded pension plans by following the process described in ERISA, which releases employers from their obligations under terminated plans if they purchase an annuity or pay a lump sum that replaces the pension benefits.
“What employers liked about ERISA is that it was a clear statute that identified their risk by making it plain what they could and could not do in pension plan terminations,” says Peter Goodman, a partner at Andrews Kurth.
Until the Supreme Court ruling, however, a novel argument by union lawyers threatened to undermine that certainty.
Disaster Averted
When Crown Vantage Inc., a Cincinatti-based paper products manufacturer, filed for bankruptcy in 2000, it also decided to terminate its pension plan. The company's intention was to purchase annuities to replace the benefits–a course of action that ERISA specifically permits.
Terminating the plan gave Crown's creditors access to the $5 million surplus that existed in the fund. PACE, however, had its own designs on the money. It proposed Crown merge its plan with PACE's multiemployer fund, a course of action that would have funneled the surplus into PACE's fund.
When Crown rejected the proposal, the union filed an action in bankruptcy court alleging that Crown's directors had breached their fiduciary duties under ERISA by failing to give diligent consideration to the merger.
The bankruptcy court agreed with PACE and issued an injunction preventing Crown from obtaining the surplus. The District Court upheld the ruling, as did the 9th Circuit.
The appeals court reasoned that the decision to terminate the plan was not subject to ERISA's fiduciary obligations. But it also concluded that “the implementation of a decision to terminate” was fiduciary in nature. This meant that Crown had a fiduciary obligation to consider the merger seriously, which it had failed to do.
In the Supreme Court, Justice Antonin Scalia, who wrote the judgment, sidestepped the fiduciary issue. Vantage had no obligation to consider the merger, he concluded, because merger was an alternative to rather than a method of termination.
“Merger is fundamentally different [from termination],” Scalia stated. “It represents a continuation rather than a cessation of the ERISA regime.”
Deciding otherwise, Scalia noted, would put the court at odds with the Pension Benefit Guaranty Corporation (PBGC), which administers the federal insurance program that protects plan benefits. The PBGC's position was that ERISA didn't permit merger as a method of termination because it was in fact an alternative to termination.
“We have traditionally deferred to the PBGC when interpreting ERISA,” Scalia wrote, “for to attempt to answer these questions without the view of the agencies responsible for enforcing ERISA would be to embark upon a voyage without a compass.”
Scalia wrote that the court would defer to the PBGC's interpretation of the law as long as the interpretation was reasonable. The Court's finding that the agency's interpretation was reasonable should have been the end of it.
“Scalia could have stopped after reaching the conclusion that a merger was not a termination,” says Nell Hennessy, president and CEO of Fiduciary Counselors Inc., a consultancy.
His failure to do so leaves some important issues up in the air.
Lingering Issues
The greatest uncertainty arises from a footnote in the judgment, in which Scalia observes “Crown … could have drafted its plan documents to limit the available methods of termination, so that merger was not permitted.”
The observation is surprising in light of the court's finding that ERISA precluded merger as a means of terminating a plan.
“So the question is how far we take this footnote,” Winzeler says. “Does it suggest there's still room for argument that a merger is permissible unless specifically precluded by the plan?”
Winzeler believes that a plan allowing termination by merger would offend ERISA and be void. “But that still takes us back to why footnote 3 is in the judgment,” she says.
Hennessy opines that plan drafters will have to consider whether to “draft defensively” by clarifying that merger is prohibited as a form of termination in the plan language.
“People may start putting something about that in plans as a cautionary measure,” she says.
However, that wouldn't have helped anyone get around the broader implications had the Supreme Court upheld the 9th Circuit. Thankfully, this didn't happen.
“Despite some lingering concerns, the benefits community can sleep peacefully in the knowledge that they can continue to do things as they have always done, the insurance companies can go ahead and issue their annuities and the world will be a safer place,” Goodman says.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllHunter Biden Sues Fox, Ex-Chief Legal Officer Over Mock Trial Series
Judge Sides With McDonald's In Attorney-Client Privilege Dispute With Former Executives
4 minute readMarriott's $52M Data Breach Settlement Points to Emerging Trend
Trending Stories
- 1The Law Firm Disrupted: Playing the Talent Game to Win
- 2Preparing Your Law Firm for 2025: Smart Ways to Embrace AI & Other Technologies
- 3BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 4GlaxoSmithKline Settles Most Zantac Lawsuits for $2.2B
- 5A&O Shearman Adopts 3-Level Lockstep Pay Model Amid Shift to All-Equity Partnership
Who Got The Work
Blank Rome partner Andrew T. Hambelton has stepped in to defend Fragrancenet.com in a pending trademark infringement lawsuit. The case, filed Aug. 29 in New York Southern District Court by the Blakely Law Group, targets the defendants for allegedly selling counterfeit fragrance products. The case, assigned to U.S. District Judge Lorna G. Schofield, is 1:24-cv-06521, Abercrombie & Fitch Trading Co. v. Quester (US) Enterprises, Inc. et al.
Who Got The Work
Davis Polk & Wardwell partners Mari Grace and Edmund Polubinski III have entered appearances for Australia-based Bitcoin-mining company Iris Energy and other defendants in a pending securities class action. The action, filed Oct. 7 in New York Eastern District Court by the Rosen Law Firm, contends that the defendants concealed the inadequacy of the company's site in Childress County, Texas, including it being 'ill-equipped' and unable to operate the company's proprietary design. The case, assigned to U.S. District Judge Peggy Kuo, is 1:24-cv-07046, Williams-Israel v. Iris Energy Limited et al.
Who Got The Work
Ryan S. Stippich of Reinhart Boerner Van Deuren has entered an appearance for biopharmaceutical company Veru Inc. and other defendants in a pending shareholder derivative lawsuit. The action, filed Sept. 30 in Wisconsin Western District Court by the Brown Law Firm on behalf of June Ovadias, accuses the defendant of failing to disclose that small sample sizes and other issues rendered it unlikely that the FDA would grant Emergency Use Authorization for the cancer drug candidate sabizabulin as a potential treatment for COVID-19. The case, assigned to U.S. District Judge William M. Conley, is 3:24-cv-00676, Ovadias, June v. Steiner, Mitchell et al.
Who Got The Work
Holland & Knight partners Cynthia A. Gierhart and Thomas Willcox Brooke have entered appearances for Pakistani American Political Action Committee and Rao Kamran Ali in a pending trademark infringement lawsuit. The action, filed Sept. 24 in District of Columbia District Court by Jackson Walker on behalf of Pakistani American Public Affairs Committee, accuses the defendants of using a mark that's confusingly similar to the plaintiff's 'Pak-Pac' marks without authorization. The case, assigned to U.S. District Judge Randolph D. Moss, is 1:24-cv-02727, Pakistani American Public Affairs Committee v. Pakistani American Political Action Committee et al.
Who Got The Work
Lauren M. Rosenberg and Yonatan Even of Cravath, Swaine & Moore have stepped in to represent Israel-based Oddity Tech Ltd. in a pending securities class action. The case, filed Aug. 30 in New York Southern District Court by Pomerantz LLP and Holzer & Holzer, contends that the defendant made materially misleading statements regarding the capability of Oddity's AI technology and ongoing civil litigation, resulting in the artifical inflation of the market price of Oddity's securities. The case, assigned to U.S. District Judge Margaret M. Garnett, is 1:24-cv-06571, Hoare v. Oddity Tech Ltd. et al.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250